Neutropenia  >>  Caprelsa (vandetanib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Caprelsa (vandetanib) / Sanofi
ZACFAST, NCT00862836 / 2008-005557-38: Addition of Vandetanib to Standard Therapy Pegliposomal Doxorubicin (PLD)

Checkmark Vandetanib+pegylated liposomal doxorubicin (PLD) in recurrent ovarian cancer
Sep 2013 - Sep 2013: Vandetanib+pegylated liposomal doxorubicin (PLD) in recurrent ovarian cancer
Terminated
2
15
Europe
Vandetanib, Zactima
Genzyme, a Sanofi Company
Ovarian Cancer
09/10
09/10

Download Options